Art. 63 Directive (EU) 2001/83

In forcesince 16 Nov 2012cited 10×
1.

The particulars for labelling listed in Articles 54, 59 and 62 shall appear in an official language or official languages of the Member State where the medicinal product is placed on the market, as specified, for the purposes of this Directive, by that Member State.

The first subparagraph shall not prevent these particulars from being indicated in several languages, provided that the same particulars appear in all the languages used.

In the case of certain orphan medicinal products, the particulars listed in Article 54 may, on reasoned request, appear in only one of the official languages of the Community.

2.

The package leaflet must be written and designed in such a way as to be clear and understandable, enabling users to act appropriately, when necessary with the help of health professionals. The package leaflet must be clearly legible in an official language or official languages of the Member State where the medicinal product is placed on the market, as specified, for the purposes of this Directive, by that Member State.

The first subparagraph shall not prevent the package leaflet from being printed in several languages, provided that the same information is given in all the languages used.

3.

Where the medicinal product is not intended to be delivered directly to the patient, or where there are severe problems in respect of the availability of the medicinal product, the competent authorities may, subject to measures they consider necessary to safeguard human health, grant an exemption to the obligation that certain particulars should appear on the labelling and in the package leaflet. They may also grant a full or partial exemption to the obligation that the labelling and the package leaflet must be in an official language or official languages of the Member State where the medicinal product is placed on the market, as specified, for the purposes of this Directive, by that Member State.

  • Directive (EU) 2004/27Lawamends

  • Opinion of Advocate General Szpunar delivered on 13 January 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    In fact, in so far as the applicable legislation requires that medicinal products display certain information, both on the packaging and in a packet leaflet normally contained inside the packaging, which must be in the official language or …

    13 Jan 2022 · 62020CC0147

  • BGH, Urteil vom 30. März 2017 - I ZR 263/15Decision

    … 1 und 8 Satz 3 AMG und Art. 63 der Richtlinie 2001/83/EG einhält.

    30 Mar 2017 · KORE318682017

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    The first subparagraph of Article 63(1) of Directive 2001/83 is worded as follows: ‘The particulars for labelling listed in Articles 54, 59 and 62 shall appear in an official language or official languages of the Member State where the …

    17 Nov 2022 · 62020CJ0224

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Bayer Intellectual Property GmbH v kohlpharma GmbH.Decision

    The first subparagraph of Article 63(1) of that directive is worded as follows: ‘The particulars for labelling listed in Articles 54, 59 and 62 shall appear in an official language or official languages of the Member State where the …

    17 Nov 2022 · 62020CJ0204

  • Opinion of Advocate General Szpunar delivered on 11 June 2026.Decision

    … национални разпоредби транспонират член 54, член 55, параграф 3 и член 63, параграф 1 от Директива 2001/83, запитващата юрисдикция иска, на …

    11 Jun 2026 · 62025CC0354

  • BVerwG, EuGH-Vorlage vom 20. März 2025 - 3 C 9/23Decision

    … 267 AEUV vorgelegt: 1. Finden die Kennzeichnungsvorgaben der Art. 54, 55 Abs. 3 und Art. 63 Abs. 1 der Richtlinie 2001/83/EG auf ein Arzneimittel Anwendung, für das in einem Mitgliedstaat eine Genehmigung für das Inverkehrbringen erteilt …

    20 Mar 2025 · WBRE202500338

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    The first subparagraph of Article 63(1) of that directive is worded as follows: ‘The particulars for labelling listed in Articles 54, 59 and 62 shall appear in an official language or official languages of the Member State where the …

    17 Nov 2022 · 62020CJ0147

  • BGH, Urteil vom 30. März 2017 - I ZR 263/15Decision

    30 Mar 2017 · I_ZR_263-15

  • Regeling proeven op farmaceutische productenLaw

    … alle verplichte elementen opgenomen die in titel V voor de etikettering van geneesmiddelen voor menselijk gebruik (artikel 63 van richtlijn 2001/83) en voor de bijsluiter (artikel 59 van richtlijn 2001/83 ) zijn vermeld. 1.3.3. Model en …